0 Évaluations

ID

22741

Description

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Mots-clés

  1. 11/06/2017 11/06/2017 -
Détendeur de droits

Genentech, Inc.

Téléchargé le

11 juin 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :


    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    CONCOMITANT MEDICATIONS (DAY 0 - MONTH 12) CRFs Roche FVF4170G Macular Edema NCT00473382

    CONCOMITANT MEDICATIONS (DAY 0 - MONTH 12) CRFs Roche FVF4170G Macular Edema NCT00473382

    Patient administration
    Description

    Patient administration

    Subject Number
    Description

    PT

    Type de données

    integer

    Alias
    UMLS CUI [1]
    C2348585 (Clinical Trial Subject Unique Identifier)
    Subject Initials:
    Description

    PTINIT

    Type de données

    text

    Alias
    UMLS CUI [1,1]
    C1997894 (Clinical trial participant (person))
    SNOMED
    428024001
    UMLS CUI [1,2]
    C2986440 (Person Initials)
    Report Date:
    Description

    VDT

    Type de données

    date

    Alias
    UMLS CUI [1,1]
    C1302584 (Date of report)
    SNOMED
    399651003
    CONCOMITANT MEDICATIONS (DAY 0 - MONTH 12)
    Description

    CONCOMITANT MEDICATIONS (DAY 0 - MONTH 12)

    Were any medications taken?
    Description

    If Yes, record all medication beginning 7 days prior to Day 0. If indication for medication is an adverse event, complete appropriate Adverse Event CRF.

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0013216 (Pharmacotherapy)
    SNOMED
    416608005
    Medication
    Description

    Medication

    Line Number
    Description

    LINE_NUMBER [LN]

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C0449788 (Count of entities)
    SNOMED
    410681005
    UMLS CUI [1,2]
    C0087111 (Therapeutic procedure)
    SNOMED
    277132007
    LOINC
    LP21090-3
    Medication
    Description

    MED_RAW_TERM [MDRAW]

    Type de données

    text

    Alias
    UMLS CUI [1]
    C0013216 (Pharmacotherapy)
    SNOMED
    416608005
    Indication(s)
    Description

    MED_INDICATION [MDIND]

    Type de données

    text

    Alias
    UMLS CUI [1,1]
    C0013216 (Pharmacotherapy)
    SNOMED
    416608005
    UMLS CUI [1,2]
    C0392360 (Indication of (contextual qualifier))
    SNOMED
    230165009
    LOINC
    MTHU008319
    Date Started
    Description

    START_DT [STRDT]

    Type de données

    date

    Unités de mesure
    • DD/MMM/YY
    Alias
    UMLS CUI [1]
    C0808070 (Start Date)
    DD/MMM/YY
    Date Stopped
    Description

    STOP_DT [STPDT]

    Type de données

    date

    Unités de mesure
    • DD/MMM/YY
    Alias
    UMLS CUI [1]
    C0806020 (End date)
    SNOMED
    454551000124105
    LOINC
    MTHU008302
    DD/MMM/YY
    Eye
    Description

    EYE [EYE]

    Type de données

    integer

    Alias
    UMLS CUI [1]
    C0015392 (Eye)
    SNOMED
    81745001
    LOINC
    LP7218-3
    Eye Code
    Description

    EYE_CODE [EYECD]

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C0015392 (Eye)
    SNOMED
    81745001
    LOINC
    LP7218-3
    UMLS CUI [1,2]
    C0805701 (Code)

    Similar models

    CONCOMITANT MEDICATIONS (DAY 0 - MONTH 12) CRFs Roche FVF4170G Macular Edema NCT00473382

    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    Patient administration
    PT
    Item
    Subject Number
    integer
    C2348585 (UMLS CUI [1])
    PTINIT
    Item
    Subject Initials:
    text
    C1997894 (UMLS CUI [1,1])
    C2986440 (UMLS CUI [1,2])
    VDT
    Item
    Report Date:
    date
    C1302584 (UMLS CUI [1,1])
    Item Group
    CONCOMITANT MEDICATIONS (DAY 0 - MONTH 12)
    MED_RECORDS [MDREC]
    Item
    Were any medications taken?
    boolean
    C0013216 (UMLS CUI [1])
    Item Group
    Medication
    LINE_NUMBER [LN]
    Item
    Line Number
    integer
    C0449788 (UMLS CUI [1,1])
    C0087111 (UMLS CUI [1,2])
    MED_RAW_TERM [MDRAW]
    Item
    Medication
    text
    C0013216 (UMLS CUI [1])
    MED_INDICATION [MDIND]
    Item
    Indication(s)
    text
    C0013216 (UMLS CUI [1,1])
    C0392360 (UMLS CUI [1,2])
    START_DT [STRDT]
    Item
    Date Started
    date
    C0808070 (UMLS CUI [1])
    STOP_DT [STPDT]
    Item
    Date Stopped
    date
    C0806020 (UMLS CUI [1])
    Item
    Eye
    integer
    C0015392 (UMLS CUI [1])
    CL Item
    NA (1)
    CL Item
    OD (2)
    CL Item
    OS (3)
    Item
    Eye Code
    integer
    C0015392 (UMLS CUI [1,1])
    C0805701 (UMLS CUI [1,2])
    Code List
    Eye Code
    CL Item
    Topical (1 )
    CL Item
    Subconjunctival (2 )
    CL Item
    Intracranial (anterior chamber) (3 )
    CL Item
    Intravitreal (4 )
    CL Item
    Posterior Subtenon’s (5 )
    CL Item
    Other (99 )

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial